Pharmacotherapy for Pediatric Generalized Anxiety Disorder: A Systematic Evaluation of Efficacy, Safety and Tolerability

被引：0
|
作者：
Eric T. Dobson
Jeffrey R. Strawn
机构：
[1] University of Cincinnati,Department of Psychiatry and Behavioral Neuroscience
[2] College of Medicine,Department of Psychiatry
[3] Cincinnati Children’s Hospital Medical Center,undefined
来源：
Pediatric Drugs | 2016年 / 18卷
关键词：
Anxiety Disorder; Generalize Anxiety Disorder; Sertraline; Social Anxiety Disorder; Duloxetine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：45 / 53
页数：8
相关论文
共 50 条
  • [41] Can Long-Term Pharmacotherapy Prevent Relapses in Generalized Anxiety Disorder? A Systematic Review
    Marina Dyskant Mochcovitch
    Rafael Christophe da Rocha Freire
    Rafael Ferreira Garcia
    Antonio Egidio Nardi
    Clinical Drug Investigation, 2017, 37 : 737 - 743
  • [42] EFFICACY AND TOLERABILITY OF ANTIDEPRESSANTS IN PEDIATRIC ANXIETY DISORDERS: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Strawn, Jeffrey R.
    Welge, Jeffrey A.
    Wehry, Anna M.
    Keeshin, Brooks
    Rynn, Moira A.
    DEPRESSION AND ANXIETY, 2015, 32 (03) : 149 - 157
  • [43] A flexible dose open label trial evaluating the efficacy and safety of quetiapine (Seroquel®) as adjunctive pharmacotherapy for the treatment of generalized anxiety disorder (GAD)
    Katzman, M. A.
    Vermani, M.
    Jacobs, L.
    Marcus, M.
    Lessard, S.
    Galarraga, W.
    Kong, B. Y.
    Struzik, L.
    Gendron, A.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S117 - S117
  • [44] Efficacy and tolerability of pharmacotherapy for obsessive-compulsive personality disorder: a systematic review of randomized controlled trials
    Gecaite-Stonciene, Julija
    Williams, Taryn
    Lochner, Christine
    Hoffman, Jacob
    Stein, Dan J.
    EXPERT OPINION ON PHARMACOTHERAPY, 2022, 23 (11) : 1351 - 1358
  • [45] Erratum: Efficacy and Tolerability of an mGlu2/3 Agonist in the Treatment of Generalized Anxiety Disorder
    Eduardo Dunayevich
    Janelle Erickson
    Louise Levine
    Ronald Landbloom
    Darryle D Schoepp
    Gary D Tollefson
    Neuropsychopharmacology, 2008, 33 (10) : 2549 - 2549
  • [46] First-Line Pharmacotherapy Approaches for Generalized Anxiety Disorder
    Davidson, Jonathan R. T.
    JOURNAL OF CLINICAL PSYCHIATRY, 2009, 70 : 25 - 31
  • [47] Pregabalin for the treatment of generalized anxiety disorder (GAD): Efficacy and safety in elderly patients
    Garcia, J. Bobes
    Montgomery, S.
    Baldinetti, F.
    Leon, T.
    Mandel, F.
    Pauer, L.
    Chatamra, K.
    EUROPEAN PSYCHIATRY, 2007, 22 : S280 - S280
  • [48] Safety and efficacy of escitalopram in the long-term treatment of generalized anxiety disorder
    Davidson, JRI
    Bose, A
    Wang, Q
    JOURNAL OF CLINICAL PSYCHIATRY, 2005, 66 (11) : 1441 - 1446
  • [49] Efficacy and safety of venlafaxine ER in the treatment of children and adolescents with generalized anxiety disorder
    Yeung, P
    Kunz, N
    Rynn, M
    Riddle, M
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S194 - S195
  • [50] EFFICACY OF DULOXETINE FOR GENERALIZED ANXIETY DISORDER: A META-ANALYSIS AND SYSTEMATIC REVIEW
    Puli, V.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2010, 24 : A70 - A70
12345